Catalio Capital Management

What they do

Catalio Capital Management is a New York-based investment firm focused on innovative healthcare investing across private equity, structured opportunities, public equities, and co-investments. The firm invests in breakthrough biotech, healthcare, and AI-driven healthcare companies across all stages and throughout the capital structure. Catalio manages approximately $2 billion in assets and supports a portfolio spanning drugs, healthcare/AI, devices, diagnostics, and other healthcare-related categories. It operates with a team of over 40 employees across offices in New York City, Washington, DC, and London.

What they look for

Invests in innovative healthcare and biotech companies at all stages, including drugs, healthcare/AI, devices, and diagnostics, across private equity, structured opportunities, public equities, and co-investments, with a focus on building category-defining businesses.

Stage

Ideation, Pre-seed, Seed, Series A, Series B+

Sectors

Healthcare, AI

Based

New York City, US